Last updated 2026-07-20
- Acquired by Chemomab Ltd., Mar 2021
- Raised $4.7M PIPE led by Palisade Capital Management, Sep 2016
- Raised $4M PIPE led by Clal Biotechnology Industries (CBI), Oct 2012
Total raised
$8.7M
Last: Undisclosed Round 2016-10
Stage
Acquired
Founded
2004
Headcount
1-10
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Anchiano Therapeutics was a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies to treat cancer. It was formerly known as BioCancell Ltd. and developed a gene therapy technology based on introducing a “Trojan horse” into cancer cells. The company merged with Chemomab Ltd. in March 2021.
Funding history · 6 rounds · $8.7M total
2018-12
Follow-on PO
Undisclosed
2018-07
Follow-on PO
Undisclosed
2016-09
PIPE
$4.7M
★ Palisade Capital Management
2016-04
Follow-on PO
Undisclosed
2012-10
PIPE
$4.0M
★ Clal Biotechnology Industries (CBI)
2006-07
Follow-on PO
Undisclosed
Headcount over time
From 20 (2015-06) to 1 (2024-08) · -19 (-95%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Anchiano Therapeutics' primary focus?
- Anchiano Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat cancer-related diseases.
- What is Anchiano Therapeutics' most advanced product candidate?
- Anchiano Therapeutics' most advanced product candidate is BC-819, which is under development as a treatment for non-muscle-invasive bladder cancer.
- Does Anchiano Therapeutics have a second-generation drug in development?
- Yes, Anchiano Therapeutics is developing BC-821, a second-generation drug for the systemic treatment of advanced malignant neoplasms. Preclinical studies have shown its efficacy in various cancer animal models.
- When was Anchiano Therapeutics acquired and by whom?
- Anchiano Therapeutics was acquired by Chemomab Therapeutics in March 2021.
- What is the total amount of funding Anchiano Therapeutics raised?
- Anchiano Therapeutics raised a total of $37.7 million USD.
- Which company is a direct subsidiary of Clal Biotechnology Industries Ltd.?
- Anchiano Therapeutics is a direct subsidiary of Clal Biotechnology Industries Ltd.
- How many employees does Anchiano Therapeutics have?
- Anchiano Therapeutics has 1-10 employees.
- Who is the Co-Founder and Chief Scientist of Anchiano Therapeutics?
- Prof. Avraham Hochberg (Late) is the Co-Founder and Chief Scientist of Anchiano Therapeutics.
Team · 1
Prof. Avraham Hochberg
Founder · Founder, Chief Scientist
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
cancerbiotechnologybiopharmaceuticalcell-therapybiopsytargeted-therapypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | anchiano.com |
|---|---|
| linkedin.com/company/33255574 |
Identifiers & details
| Legal name | Anchiano Therapeutics Ltd. |
|---|---|
| Former names | BioCancell Therapeutics |
| Founded | 2004 |
| Offices | Cambridge |
| Status reason | Acquired (Inactive) by Chemomab Therapeutics on Mar 2021 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Chemomab Ltd. 2021-03
Radar intelligence
Web history (Wayback)
| Domain | anchiano.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513597856 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2004-10-18 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — violation (1), annual_report (1) |
| Registered address | אלון יגאל 98 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-26 | עדכון הפרה |
| 2026-05-26 | דו~ח שנתי |